Streetbeat News

Products Services

NBIX

Neurocrine Biosciences presented data from the CAHtalyst adult study at AACE 2024, highlighting the need for new treatments to reduce adrenal androgens and supraphysiologic glucocorticoid dosing in CAH adult patients. The study also reviewed the psychological and cognitive impacts of high glucocorticoid doses in CAH patients.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:49 pm

MSTR

Deep-pocketed investors show a bearish sentiment towards MicroStrategy (NASDAQ:MSTR), with options trading data revealing a mix of bullish and bearish positions. The trading focuses on a price range between $170.0 and $1870.0. The largest trades include both calls and puts with varying sentiments and strike prices. MicroStrategy, a provider of enterprise analytics and mobility software, has seen its stock price slightly decrease by -0.32%, with a current price of $1229.19. Analysts have mixed views, with target prices ranging from $1590 to $1875.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 1:47 pm

BABA

ONLN

PGJ

Alibaba Group Holding Limited (NYSE:BABA) announced the release of its new AI model, Tongyi Qianwen Qwen2.5, through Alibaba Cloud, claiming superior language skills over OpenAI's GPT-4. The model has seen over 90,000 deployments and aims to leverage the surge in generative AI development. Despite outperforming GPT-4 in language creation, it may lag in other areas. Alibaba Cloud has attracted over 2.2 million corporate users for its AI services and has made significant price cuts in its cloud services. Alibaba's stock is accessible through ETFs like the Invesco Golden Dragon China ETF (NASDAQ:PGJ) and the ProShares Online Retail ETF (NYSE:ONLN).

Portfolio Pulse from Anusuya Lahiri

May 09, 2024 | 1:42 pm

TOON

Kartoon Studios, Inc. (NYSE:TOON) has entered into a partnership with GFM Animation Limited to develop, finance, and produce five animated feature films from the Stan Lee Universe. This deal marks a significant step in utilizing the extensive catalogue of characters and stories created by Stan Lee. The collaboration aims to appeal to a broad audience and families, with the first three treatments to be presented at the upcoming Cannes Film Festival.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:41 pm

CAPR

Capricor Therapeutics announced it will present new preclinical data on its StealthX exosome platform at the ASGCT 27th Annual Meeting, highlighting its potential in treating arginase-1 deficiency (ARG1-D), a rare genetic metabolic disease. The findings suggest the platform's capability for enzyme-replacement therapies, aiming to replace deficient or absent enzymes. The company aims to leverage partnerships to advance therapeutic and vaccine development using this technology.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:39 pm

RPD

Rapid7, Inc. (NASDAQ:RPD) announced new patented ransomware prevention technology, enhancing its threat detection capabilities and response times for advanced attacks.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:37 pm

TTEK

Tetra Tech, Inc. (NASDAQ:TTEK) has acquired Convergence Controls & Engineering, enhancing its digital water and energy practices. This acquisition brings in expertise in process automation, systems integration, and cybersecurity, aligning with Tetra Tech's Leading with Science approach to offer integrated automation platforms for real-time data visualization and analytics. The terms of the acquisition were not disclosed, and Convergence will join Tetra Tech's Government Services Group.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:31 pm

LAW

CS Disco, a legal technology company, has introduced Cecilia Doc Summaries, a new AI feature designed to help legal professionals quickly comprehend extensive case documents and accelerate the evidence gathering process. This development is part of the company's ongoing efforts to incorporate advanced generative AI capabilities into its offerings.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:31 pm

ATAI

CMPS

CYBN

KAYS

Kaya Holdings Inc. (OTCQB:KAYS), a Florida-based cannabis company, has been granted a license by the Oregon Health Authority to operate a Psilocybin Service Center named The Sacred Mushroom in Oregon. This center, under its subsidiary Fifth Dimension Therapeutics, Inc., aims to provide psilocybin treatment in a unique setting, expecting to welcome its first guests within the next thirty days. The move is seen as a significant step in the mental health sector, with KAYS aiming to become a leader in psychedelic care delivery. Other companies like Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI), and Cybin (AMEX:CYBN) are developing synthetic psilocybin for treatment-resistant mental health disorders, expected to be administered in centers like The Sacred Mushroom.

Portfolio Pulse from Nina Zdinjak

May 09, 2024 | 1:29 pm

NITO

N2OFF has achieved a significant milestone in reducing agriculture's environmental impact, with a recent greenhouse study showing a reduction of emissions by up to 54%, an improvement over the previous reduction of up to 44%.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:29 pm